Borgess Institutional Review Board (IRB)

The primary responsibility of the Institutional Review Board (IRB) is to assure that the rights and welfare of the human subjects involved in research at Borgess Medical Center are adequately protected and that human subjects are not exposed to inappropriate risks.

The IRB will assist investigators in designing their research projects in a manner that minimizes potential harm to human subjects, will review all planned research involving human subjects prior to initiation of the research, will approve research that meets established criteria for protection of human subjects, and will monitor approved research to ensure that human subjects have given informed consent to participate in the research and ensure that human subjects remain protected during the entire course of a study.

Institutional Review Board Guidelines (pdf)

Section 8 Exhibits

A. Protocol Submission Checklist & Study Summary

B. Informed Consent Template

B2. Informed Consent Instructions

C. HIPAA Researcher Application for Waiver

C1. H1 Preparatory to Research

C2. H2 Request for Waiver

C3. H3 Decedent Research

D. Approval Letter

E. Continuation Review Application

E2. Continuation Review Instructions

F. BMC SAE Reporting Form

F2. SAE Instructions

G. SAE Summary Report

H. Genetic Informed Consent Template

I. Close Out Report

I2. Close Out Instructions

J. BH Conflict of Interest Form

K. Statement of Investigator Compliance

Any research protocol that will be conducted on the Borgess Medical Center Gull Road campus or offsite facilities (Borgess Health & Fitness Center, Borgess-Pipp Hospital, and Borgess at Woodbridge Hills) will be reviewed by the IRB. The IRB office is located in the Borgess Research Institute, North Professional Building, Suite 003. Richard Lammers, MD, is the chairperson of the IRB, and Joan Sutherland, Research Compliance Coordinator, is the primary contact; both can be reached at 269-226-7341.